期刊文献+

强直性脊柱炎患者外周血Th17细胞比率及其相关细胞因子的表达 被引量:3

下载PDF
导出
摘要 目的研究强直性脊柱炎(AS)不同疾病状态外周血Th17细胞比率及其相关细胞因子表达情况,探讨其与AS炎症活动的关系。方法 41例AS患者按Bath强直性脊柱炎活动性分为活动组(n=22)和稳定组(n=19),14例健康人作为对照。采用流式细胞术检测外周血Th17细胞比率,ELISA法检测血浆中的IL-17、IL-1β、IL-6、IL-23及肿瘤坏死因子-α(TNF-α)蛋白水平。结果活动组外周血Th17细胞比率明显高于稳定组及对照组(P<0.05或<0.01)。活动组血浆中IL-17平均浓度以及IL-1β、IL-6、IL-23、TNF-α等表达水平均明显高于稳定组及对照组(P均<0.01);IL-17、IL-1β、IL-6、IL-23、TNF-α之间呈显著相关(P<0.05或<0.01)。结论 Th17及相关细胞因子可能与AS炎症高度活动相关。
出处 《山东医药》 CAS 北大核心 2010年第49期89-91,共3页 Shandong Medical Journal
基金 泉州科技局资助项目(2008Z-17)
  • 相关文献

参考文献7

  • 1王新卫,林智明,廖泽涛,魏秋静,江颖娟,古洁若.IL-23与IL-17在强直性脊柱炎患者中表达的初步研究[J].中国免疫学杂志,2009,25(3):266-270. 被引量:30
  • 2Garrett S,Jenkinson T,Kennedy LG,et al.A new approach to defining disease status in ankylosings pondylitis:the bath ankylosing spondylitis disease activity indes[J].Rheumatology,1994,21(12):2286-2291.
  • 3Fouser LA,Wright JF,Dunussi-Joannopoulos K,et al.Th17cytokines and their emerging roles in inflammation and autoimmunity[J].Immunol Rev,2008,226:87-102.
  • 4苏金梅,张文,唐福林.强直性脊柱炎研究进展——2008年欧洲风湿病联盟年会纪要[J].中华临床免疫和变态反应杂志,2009,3(1):78-79. 被引量:12
  • 5Acosta-Rodriguez EV,Napolitani G,Lanzavecchia A,et al.Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells[J].Nat Immunol,2007,8(9):942-949.
  • 6Iwakura Y,Ischigame H.The IL-23/IL-17 axis in inflammation[J].J Clin Invest,2006,116(1):1218-1222.
  • 7Van den berg W.The role of cytokines and growth factors in cartilage destruction of osteoarthritis and rheumatoid arthritis[J].Z Rheumatol,1999,58(3):136-141.

二级参考文献1

共引文献39

同被引文献38

  • 1杨再兴,梁艳,朱烨,李畅,张玲珍,仲人前.强直性脊柱炎患者血清IL-12水平及临床意义研究[J].中国实验诊断学,2007,11(5):619-621. 被引量:10
  • 2THOMAS G P, BROWN M A. Genetics and genomics of ankylo- sing spondylitis[ J]. Immunol Rev, 2010, 233 ( 1 ) : 162 - 180.
  • 3BROWN M A, KENNEDY L G, MACGREGOR A J, et al. Sus- ceptibility to AS in twins: the role of genes, HLA, and the envi- ronment[J]. Arthritis Rheum, 1997, 40(10) : 1823 - 1828.
  • 4ZOCHLING J, BRAUN J. Mortality in ankylosing spondylitis[ J]. Clin Exp Rheumatol, 2008, 26(5 Suppl 51 ) : S80- S84.
  • 5JASKELIOFF M, PETERSON C L. Chromatin and transcription: histones continue to make their marks[ J]. Nat Cell Biol, 2003,5 (11) : 395 -399.
  • 6FISCHLE W, WANG Y, ALLIS C D. Histone and chromatin cross - talk[J]. Curt Opin Cell Biol, 2003, 15(2) : 172 -183.
  • 7LACHNER M O, SULLIVAN R J, JENUWEIN T. An epigenetic road map for histone lysine methylation [ J]. J Cell Sei, 2003, 116 (10) : 2117 -2124.
  • 8SANTOS ROSA H, SCHNEIDER R, BANNISTER A J, et al.Active genes are tri -methylated at K4 of histone H3 [ J]. Nature, 2002, 419(6905): 407-411.
  • 9GOLL M G, BESTOR T H. Histone modification and replacement in chromatin activation[J]. Genes Dev, 2002, 16(14) : 1739 - 1742.
  • 10LARIBEE R N, KROGAN N J, XIAO T, et al. BUR kinase se- lectively regu - lates H3 - K4 trimethylation and H2B ubiquityla- tion through recruitment of the PAF elongation complex [ J ]. CmT Biol, 2005, 15(16): 1487-1493.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部